Adagene Inc (ADAG)

Adagene Inc (ADAG) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $165M; returns 1 day -1.2%, 1 week +17.0%, 1 year +34.6%.

Adagene Inc. is a clinical-stage biopharmaceutical company based in Suzhou, China, dedicated to the discovery and development of novel antibody-based cancer immunotherapies.

Groups ADAG belongs to

• Biotechnology
• Clinical Stage Biotech
• China Companies
• Oncology
• Cancer Therapeutics
• Immunotherapy
• Biopharmaceutical
• Antibody Therapeutics
• Healthcare
• Drug Discovery
• China Healthcare
• Life Sciences
• Antibody-Drug Conjugates
• Bispecific Antibodies

ADAG financial model: income statement, cash flow and balance sheet